190 related articles for article (PubMed ID: 36592414)
21. Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challenges.
Abrahams T; Nicholls SJ
Expert Opin Drug Discov; 2024 Mar; 19(3):281-290. PubMed ID: 38402906
[TBL] [Abstract][Full Text] [Related]
22. Standardizing and increasing the utility of lipidomics: a look to the next decade.
Wang Y; Yutuc E; Griffiths WJ
Expert Rev Proteomics; 2020 Oct; 17(10):699-717. PubMed ID: 33191815
[No Abstract] [Full Text] [Related]
23. Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.
Rankin NJ; Preiss D; Welsh P; Sattar N
Int J Epidemiol; 2016 Oct; 45(5):1351-1371. PubMed ID: 27789671
[TBL] [Abstract][Full Text] [Related]
24. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson's disease.
Gątarek P; Kałużna-Czaplińska J
Expert Rev Proteomics; 2024; 21(1-3):13-25. PubMed ID: 38346207
[TBL] [Abstract][Full Text] [Related]
25. Lipidomics for studying metabolism.
Han X
Nat Rev Endocrinol; 2016 Nov; 12(11):668-679. PubMed ID: 27469345
[TBL] [Abstract][Full Text] [Related]
26. The metabolomics and lipidomics window into thyroid cancer research.
Farrokhi Yekta R; Rezaie Tavirani M; Arefi Oskouie A; Mohajeri-Tehrani MR; Soroush AR
Biomarkers; 2017 Nov; 22(7):595-603. PubMed ID: 27805426
[TBL] [Abstract][Full Text] [Related]
27. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update.
Kale D; Fatangare A; Phapale P; Sickmann A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132115
[TBL] [Abstract][Full Text] [Related]
28. Enantioselectivity Effects in Clinical Metabolomics and Lipidomics.
Oliveira RV; Simionato AVC; Cass QB
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500665
[TBL] [Abstract][Full Text] [Related]
29. Lipidomic profiles as a tool to search for new biomarkers.
Pisarska A; Wąsowicz W; Gromadzińska J
Int J Occup Med Environ Health; 2022 Apr; 35(2):111-126. PubMed ID: 35072665
[TBL] [Abstract][Full Text] [Related]
30. Clinical lipidomics: realizing the potential of lipid profiling.
Meikle TG; Huynh K; Giles C; Meikle PJ
J Lipid Res; 2021; 62():100127. PubMed ID: 34582882
[TBL] [Abstract][Full Text] [Related]
31. Mass-spectrometry-based lipidomics.
Hu T; Zhang JL
J Sep Sci; 2018 Jan; 41(1):351-372. PubMed ID: 28859259
[TBL] [Abstract][Full Text] [Related]
32. Lipidomics: An excellent tool for chronic disease detection.
B A; Waseem M; Kashif M; Srinivasan H
Curr Res Transl Med; 2022 Sep; 70(4):103346. PubMed ID: 35487168
[TBL] [Abstract][Full Text] [Related]
33. Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.
Yang K; Han X
Trends Biochem Sci; 2016 Nov; 41(11):954-969. PubMed ID: 27663237
[TBL] [Abstract][Full Text] [Related]
34. NIST lipidomics workflow questionnaire: an assessment of community-wide methodologies and perspectives.
Bowden JA; Ulmer CZ; Jones CM; Koelmel JP; Yost RA
Metabolomics; 2018 Mar; 14(5):53. PubMed ID: 30830346
[TBL] [Abstract][Full Text] [Related]
35. Lipidomics: new insight into kidney disease.
Zhao YY; Vaziri ND; Lin RC
Adv Clin Chem; 2015; 68():153-75. PubMed ID: 25858872
[TBL] [Abstract][Full Text] [Related]
36. Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease.
Hinterwirth H; Stegemann C; Mayr M
Circ Cardiovasc Genet; 2014 Dec; 7(6):941-54. PubMed ID: 25516624
[TBL] [Abstract][Full Text] [Related]
37. Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes.
Yen NTH; Anh NK; Jayanti RP; Phat NK; Vu DH; Ghim JL; Ahn S; Shin JG; Oh JY; Long NP; Kim DH
Biochimie; 2023 Aug; 211():153-163. PubMed ID: 37062470
[TBL] [Abstract][Full Text] [Related]
38. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease.
Zhao YY; Miao H; Cheng XL; Wei F
Chem Biol Interact; 2015 Oct; 240():220-38. PubMed ID: 26358168
[TBL] [Abstract][Full Text] [Related]
39. Omics to Unveil Diabetes Mellitus Pathogenesis and Biomarkers: Focus on Proteomics, Lipidomics, and Metabolomics.
Soares NP; Magalhaes GC; Mayrink PH; Verano-Braga T
Adv Exp Med Biol; 2024; 1443():211-220. PubMed ID: 38409423
[TBL] [Abstract][Full Text] [Related]
40. Lipidomics: Prospects from a technological perspective.
Triebl A; Hartler J; Trötzmüller M; C Köfeler H
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):740-746. PubMed ID: 28341148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
